Hiroaki Ozasa

助教 / Assistant Professor

Kyoto University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Immunology Immunology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Noriko Kishi

Program-Specific Assistant Professor

Kyoto University Hospital

JAPAN

View details

Wataru Aoki

Kyoto University

JAPAN

View details

Tomoko Funazo

Kyoto University Hospital

JAPAN

View details

Yuki Ikematsu

JAPAN

View details

Takahiro Tsuji

Fred Hutch Cancer Center

UNITED STATES

View details

Ryusuke Hatae

Assistant Professor

Kyushu University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroaki Ozasa

Research Interests

Explore related searches

Contact this professor

Articles (10)

Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer

Salvage Surgery After Immune Checkpoint Inhibitors for Advanced Non-Small Cell Lung Cancer: Potential Association Between Immune-Related Adverse Events and Longer Survival

Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series

Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer

Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer

PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade

Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer

Thyroid metastasis of pulmonary adenocarcinoma with EGFR G719A mutation: Genetic confirmation with liquid-based cytology specimens

A randomized phase II study of maintenance bevacizumab, pemetrexed or bevacizumab plus pemetrexed for advanced non-squamous non-small cell lung cancer

Acquired resistance to alectinib in ALK-rearranged lung cancer due to ABCC11/MRP8 overexpression in a clinically paired resistance model

Collaborators (6)

Noriko Kishi

Wataru Aoki

Tomoko Funazo

Yuki Ikematsu

Takahiro Tsuji

Ryusuke Hatae

Make your next move.